rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
1
|
pubmed:dateCreated |
2006-11-3
|
pubmed:abstractText |
Previous experiments have studied separately the development of either cardiac or aortic fibrosis and stiffness in aldosterone (Aldo)-salt hypertensive rats. Our aim was to determine in vivo the effects of Aldo and the Aldo receptor antagonist eplerenone (Epl) on simultaneous changes in cardiac and arterial structure and function and their interactions.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1470-3203
|
pubmed:author |
|
pubmed:issnType |
Print
|
pubmed:volume |
7
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
31-9
|
pubmed:meshHeading |
pubmed-meshheading:17083071-Animals,
pubmed-meshheading:17083071-Aorta,
pubmed-meshheading:17083071-Blood Pressure,
pubmed-meshheading:17083071-Blotting, Northern,
pubmed-meshheading:17083071-Carotid Artery Diseases,
pubmed-meshheading:17083071-Collagen,
pubmed-meshheading:17083071-Fibrosis,
pubmed-meshheading:17083071-Heart Diseases,
pubmed-meshheading:17083071-Hypertension,
pubmed-meshheading:17083071-Immunohistochemistry,
pubmed-meshheading:17083071-Male,
pubmed-meshheading:17083071-Myocardium,
pubmed-meshheading:17083071-RNA, Messenger,
pubmed-meshheading:17083071-Rats,
pubmed-meshheading:17083071-Rats, Sprague-Dawley,
pubmed-meshheading:17083071-Receptors, Aldosterone,
pubmed-meshheading:17083071-Spironolactone,
pubmed-meshheading:17083071-Structure-Activity Relationship,
pubmed-meshheading:17083071-Vascular Diseases
|
pubmed:year |
2006
|
pubmed:articleTitle |
Differences between cardiac and arterial fibrosis and stiffness in aldosterone-salt rats: effect of eplerenone.
|
pubmed:affiliation |
INSERM U572, Paris, France.
|
pubmed:publicationType |
Journal Article,
Comparative Study
|